There are several ways that MSCs can promote drug resistance in cancer cells, mostly through the secretion of cytokines like IL-6, IL-7, and IL-8, for example, in head and neck carcinomas, where these molecules induce paclitaxel resistance [32]. Here, CXCL8 is linked to head and neck carcinoma.